Brief: SpectraCure Announces Preliminary Results From Co's Prostate Treatment
May 23 (Reuters) - SpectraCure AB (publ) SPEC.ST :
* ANNOUNCES PRELIMINARY RESULTS FROM CO'S PROSTATE TREATMENT
* SAYS CLEAR TREATMENT EFFECT IS SEEN IN MR IMAGE IN
TREATMENT
AREA, INDICATING DESTRUCTION OF CANCER TUMOR
* AFTER TREATMENT, PSA LEVELS REDUCTION IN RANGE OF 50-73%
Source text for Eikon: ID:nWkr62glhG
Further company coverage: SPEC.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))